The GSP® Neonatal IRT assay allows the quantitative determination of IRT from dried blood spot specimens, and is intended as an aid in screening for cystic fibrosis.
false falseUS only; All PerkinElmer neonatal products may not be available in all countries.
The diagnosis of cystic fibrosis is often based on the symptoms, which may cause considerable delays in the disease intervention, and evidence indicates that early attention may be important in determining the clinical outcome. The amount of the pancreatic enzyme, immunoreactive trypsin (ogen) (IRT) has been shown to be increased in blood of CF patients especially during the first weeks after birth.
GSP Neonatal IRT assay:
The assay is based on a direct sandwich technique where two monoclonal antibodies bind to different epitopes on the target molecule. The fluorescence signal is proportional to the analyte concentration in the sample.
| Assay Technology | DELFIA |
|---|---|
| Calibration Standards | Yes |
| Detection Method | DELFIA |
| Disorders | Cystic Fibrosis |
| Product Brand Name | GSP® |
| Quantity in a Package Amount | 1152.0 Units |
| Unit Size | 1 Kit |
